TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling

Recent evidence has shown that the induction of ferroptosis is a new therapeutic strategy for advanced prostate cancer (PCa) when used as a monotherapy or in combination with second-generation antiandrogens. However, whether ferroptosis inducers are effective against docetaxel-resistant PCa remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xingkang, Guo, Shanqi, Xu, Mengyao, Ma, Baojie, Liu, Ranlu, Xu, Yong, Zhang, Yangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985761/
https://www.ncbi.nlm.nih.gov/pubmed/35402284
http://dx.doi.org/10.3389/fonc.2022.862015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985761/
https://www.ncbi.nlm.nih.gov/pubmed/35402284
http://dx.doi.org/10.3389/fonc.2022.862015

Ejemplares similares